Prudential Financial Inc Verona Pharma PLC Transaction History
Prudential Financial Inc
- $67.5 Billion
- Q1 2025
A detailed history of Prudential Financial Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Prudential Financial Inc holds 140,000 shares of VRNA stock, worth $14.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
140,000
Previous 208,100
32.72%
Holding current value
$14.7 Million
Previous $9.66 Million
8.03%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
293Shares Held
74.2MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$688 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$578 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$411 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$362 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$303 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.39B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...